摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1243243-29-9

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1243243-29-9
化学式
C21H18Cl3NO4S
mdl
——
分子量
486.803
InChiKey
LERMIOSSMQXFEZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.61
  • 重原子数:
    30.0
  • 可旋转键数:
    6.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    65.37
  • 氢给体数:
    0.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    在 potassium hydroxide 、 盐酸 作用下, 以 甲醇 为溶剂, 生成 5-(4-Chlorophenyl)-4-(2,4-dichlorophenyl)-1-(2-methylsulfonylethyl)pyrrole-2-carboxylic acid
    参考文献:
    名称:
    Rational design of a novel peripherally-restricted, orally active CB1 cannabinoid antagonist containing a 2,3-diarylpyrrole motif
    摘要:
    A new series of 2,3-diarylpyrroles have been prepared and evaluated as CB1 antagonists. Modulation of the topological polar surface area allowed the identification of high affinity peripherally-restricted CB1 antagonists. Compound 11, obtained after further optimization of the metabolic profile displayed very low brain penetration, yet was able to reverse CP55940-induced gastrointestinal transit inhibition following oral administration. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.06.017
  • 作为产物:
    描述:
    Methyl 5-(4-chlorophenyl)-4-(2,4-dichlorophenyl)-1H-pyrrole-2-carboxylate 、 甲基乙烯砜苄基三甲基氢氧化铵 作用下, 以 1,4-二氧六环 为溶剂, 生成
    参考文献:
    名称:
    Rational design of a novel peripherally-restricted, orally active CB1 cannabinoid antagonist containing a 2,3-diarylpyrrole motif
    摘要:
    A new series of 2,3-diarylpyrroles have been prepared and evaluated as CB1 antagonists. Modulation of the topological polar surface area allowed the identification of high affinity peripherally-restricted CB1 antagonists. Compound 11, obtained after further optimization of the metabolic profile displayed very low brain penetration, yet was able to reverse CP55940-induced gastrointestinal transit inhibition following oral administration. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.06.017
点击查看最新优质反应信息